1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. EXACT SCIENCES CORP.
Exact Sciences Corp.
XNAS: EXAS
Expensive Rocket

Watchlist

Portfolio

Alert


Insider Trading disclosures for Exact Sciences Corp

The latest disclosure was made by Jacob Orville in Exact Sciences Corp where a trade of 53,323 Common Stock done was reported to US exchanges on March 23, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jacob Orville EVP, GM, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 53,323 153,726 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 38,707 0 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 6,581 0 - - Stock Options (Right to Buy)
Jacob Orville EVP, GM, Screening Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 1,774 0 (0%) 0% - Common Stock
Jacob Orville EVP, GM, Screening Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 153,726 0 (0%) 0% - Common Stock
Katherine S. Zanotti Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 55,361 5,398 (0%) 0% - Common Stock
Katherine S. Zanotti Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 5,398 0 (0%) 0% - Common Stock
Leslie L. Trigg Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 3,244 13,925 (0%) 0% - Common Stock
Leslie L. Trigg Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 13,925 0 (0%) 0% - Common Stock
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 18,143 0 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 100,916 0 - - Stock Options (Right to Buy)
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 34,110 0 - - Stock Options (Right to Buy)
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 66,047 0 - - Stock Options (Right to Buy)
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 235,388 0 - - Stock Options (Right to Buy)
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 117,427 0 (0%) 0% - Common Stock
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 86,750 0 (0%) 0% - Common Stock
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 46,538 0 (0%) 0% - Common Stock
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 29,061 0 (0%) 0% - Common Stock
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 1,397,738 0 (0%) 0% - Common Stock
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 119,312 1,397,738 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 83,360 0 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 154,829 0 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 44,336 0 - - Restricted Stock Units
Kimberly J. Popovits Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 9,656 0 (0%) 0% - Common Stock
Kimberly J. Popovits Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 6,725 9,656 (0%) 0% - Common Stock
Paul J. Clancy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 5,398 0 (0%) 0% - Common Stock
Paul J. Clancy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 20,640 5,398 (0%) 0% - Common Stock
James E. Doyle Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 52,564 5,398 (0%) 0% - Common Stock
James E. Doyle Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 5,398 0 (0%) 0% - Common Stock
D. Scott Coward Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 4,694 0 (0%) 0% - Common Stock
D. Scott Coward Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 5,398 0 (0%) 0% - Common Stock
D. Scott Coward Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 52,164 5,398 (0%) 0% - Common Stock
D. Scott Coward Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 12,875 0 - - Stock Options (Right to Buy)
D. Scott Coward Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 10,786 0 - - Stock Options (Right to Buy)
D. Scott Coward Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 4,175 0 - - Stock Options (Right to Buy)
Shacey Petrovic Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 16,406 5,398 (0%) 0% - Common Stock
Shacey Petrovic Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 5,398 0 (0%) 0% - Common Stock
Shacey Petrovic Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 7,095 0 (0%) 0% - Common Stock
Sarah Condella EVP, Human Resources Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 191,891 0 (0%) 0% - Common Stock
Sarah Condella EVP, Human Resources Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 21,948 0 - - Stock Options (Right to Buy)
Sarah Condella EVP, Human Resources Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 11,700 0 - - Stock Options (Right to Buy)
Sarah Condella EVP, Human Resources Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 7,790 0 - - Stock Options (Right to Buy)
Sarah Condella EVP, Human Resources Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 6,581 0 - - Stock Options (Right to Buy)
Sarah Condella EVP, Human Resources Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 23,224 0 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 60,389 191,891 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 6,368 0 (0%) 0% - Common Stock
Michael J. Barber Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 7,422 0 - - Deferred Stock Units
Michael J. Barber Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 5,398 0 (0%) 0% - Common Stock
Michael J. Barber Director Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 7,738 5,398 (0%) 0% - Common Stock
Brian Baranick EVP, GM, Precision Oncology Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 137,195 0 (0%) 0% - Common Stock
Brian Baranick EVP, GM, Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 33,321 137,195 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 795 0 (0%) 0% - Common Stock
Brian Baranick EVP, GM, Precision Oncology Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 28,063 0 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 793 0 - - Stock Options (Right to Buy)
James Herriott SVP, General Counsel & Sec Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 2,861 0 - - Stock Options (Right to Buy)
James Herriott SVP, General Counsel & Sec Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 20,321 0 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 68,195 0 (0%) 0% - Common Stock
James Herriott SVP, General Counsel & Sec Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 1,762 0 (0%) 0% - Common Stock
Aaron Bloomer EVP, Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 417 0 (0%) 0% - Common Stock
Aaron Bloomer EVP, Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 4,395 0 - - Restricted Stock Units
Aaron Bloomer EVP, Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 28,063 0 - - Restricted Stock Units
Aaron Bloomer EVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Mar 2026 89,911 138,679 (0%) 0% 0 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 23 Mar 2026 138,679 0 (0%) 0% - Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.25 per share. 27 Feb 2026 8,528 1,251,570 (0%) 0% 103.3 880,516 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2026 22,168 1,273,738 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.25 per share. 27 Feb 2026 10,419 1,263,319 (0%) 0% 103.3 1,075,762 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2026 18,143 18,143 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.25 per share. 27 Feb 2026 13,060 1,278,045 (0%) 0% 103.3 1,348,445 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2026 27,786 1,291,105 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2026 27,786 83,360 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2026 22,168 44,336 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2026 18,143 1,260,098 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.38 per share. 27 Feb 2026 1,913 131,121 (0%) 0% 103.4 197,766 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.03 per share. 27 Feb 2026 3,900 133,034 (0%) 0% 5.0 19,617 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2026 3,900 0 - - Stock Options (Right to Buy)
Jacob Orville EVP, GM, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2026 38,707 38,707 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2026 13,181 1,248,151 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.45 per share. 25 Feb 2026 6,196 1,241,955 (0%) 0% 103.4 640,976 Common Stock
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2026 154,829 154,829 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2026 23,224 23,224 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2026 28,063 28,063 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2026 20,321 20,321 - - Restricted Stock Units
Aaron Bloomer EVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2026 28,063 28,063 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 13,527 53,460 (0%) 0% 101.8 1,377,319 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 6,978 38,208 (0%) 0% 101.8 710,500 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 4,442 30,341 (0%) 0% 101.8 452,284 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 14,845 45,186 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 16,051 0 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 28,779 0 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 9,450 34,783 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 1,859 25,333 (0%) 0% 101.8 189,283 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 3,955 27,192 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 28,779 66,987 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 14,845 0 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 9,450 0 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 3,955 0 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 4,426 100,403 (0%) 0% 101.8 450,655 Common Stock
Jacob Orville EVP, GM, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 9,416 104,829 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 9,675 95,413 (0%) 0% 101.8 985,109 Common Stock
Jacob Orville EVP, GM, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 20,584 105,088 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 19,986 84,504 (0%) 0% 101.8 2,034,975 Common Stock
Jacob Orville EVP, GM, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 42,523 104,490 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 7,544 61,967 (0%) 0% 101.8 768,130 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 16,051 69,511 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 155,417 1,234,970 (0%) 0% 101.8 15,824,559 Common Stock
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 330,674 155,417 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 65,014 1,059,713 (0%) 0% 101.8 6,619,725 Common Stock
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 138,326 1,124,727 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 115,118 986,401 (0%) 0% 101.8 11,721,315 Common Stock
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 244,931 1,101,519 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 3,955 0 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 3,760 129,134 (0%) 0% 101.8 382,843 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 7,560 0 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 11,876 0 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 23,817 0 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 3,554 87,948 (0%) 0% 101.8 361,868 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 3,955 85,801 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 1,859 83,942 (0%) 0% 101.8 189,283 Common Stock
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 8,000 132,894 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 15,989 124,894 (0%) 0% 101.8 1,628,000 Common Stock
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 34,018 140,883 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 11,194 106,865 (0%) 0% 101.8 1,139,773 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 23,817 118,059 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 5,582 94,242 (0%) 0% 101.8 568,359 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 7,560 91,502 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 11,876 99,824 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 8,151 58,336 (0%) 0% 101.8 829,935 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 16,051 0 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 28,779 0 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 14,845 0 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 9,450 0 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 3,955 0 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.59 per share. 23 Dec 2025 14,938 103,874 (0%) 0% 101.6 1,517,551 Common Stock
Brian Baranick EVP, GM, Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 29,416 118,812 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 10,453 89,396 (0%) 0% 101.8 1,064,324 Common Stock
Brian Baranick EVP, GM, Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 20,584 99,849 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 21,594 79,265 (0%) 0% 101.8 2,198,701 Common Stock
Brian Baranick EVP, GM, Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 42,523 100,859 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 16,051 66,487 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 14,614 50,436 (0%) 0% 101.8 1,487,997 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 28,779 65,050 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 7,539 36,271 (0%) 0% 101.8 767,621 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 14,845 43,810 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 4,799 28,965 (0%) 0% 101.8 488,634 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 9,450 33,764 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 2,009 24,314 (0%) 0% 101.8 204,556 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 3,955 26,323 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 6,530 25,600 (0%) 0% 101.8 664,885 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 1,648 13,233 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 775 12,458 (0%) 0% 101.8 78,911 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 3,780 16,238 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 1,777 14,461 (0%) 0% 101.8 180,934 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 7,125 21,586 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 3,349 18,237 (0%) 0% 101.8 340,995 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 13,893 32,934 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 7,334 0 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 13,893 0 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 7,125 0 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 3,780 0 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 1,648 0 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 7,118 67,815 (0%) 0% 101.8 724,755 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 15,144 74,933 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 14,235 59,789 (0%) 0% 101.8 1,449,408 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 30,287 74,024 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 4,644 43,737 (0%) 0% 101.8 472,852 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 9,880 48,381 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 7,995 38,501 (0%) 0% 101.8 814,051 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2025 17,009 46,496 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 3,447 29,487 (0%) 0% 101.8 350,974 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 7,334 32,934 (0%) 0% 0 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 24,384 59,571 (0%) 0% 0 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 24,384 4,395 - - Restricted Stock Units
Aaron Bloomer EVP, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 38,715 0 - - Restricted Stock Units
Aaron Bloomer EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 10,803 48,768 (0%) 0% 101.8 1,099,961 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. 23 Dec 2025 17,151 35,187 (0%) 0% 101.8 1,746,315 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Dec 2025 38,715 52,338 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Sale of securities on an exchange or to another person at price $ 75.00 per share. 19 Nov 2025 5,000 23,237 (0%) 0% 75 375,000 Common Stock
James Herriott SVP, General Counsel & Sec Sale of securities on an exchange or to another person at price $ 70.00 per share. 19 Nov 2025 1,000 11,585 (0%) 0% 70 70,000 Common Stock
Brian Baranick EVP, GM, Precision Oncology Sale of securities on an exchange or to another person at price $ 70.08 per share. 04 Nov 2025 2,858 22,368 (0%) 0% 70.1 200,289 Common Stock
James Herriott SVP, General Counsel & Sec Sale of securities on an exchange or to another person at price $ 70.08 per share. 04 Nov 2025 1,500 12,585 (0%) 0% 70.1 105,120 Common Stock
Katherine S. Zanotti Director Sale of securities on an exchange or to another person at price $ 65.00 per share. 24 Oct 2025 12,000 60,759 (0%) 0% 65 780,000 Common Stock
James E. Doyle Director Sale of securities on an exchange or to another person at price $ 60.00 per share. 09 Oct 2025 2,000 57,962 (0%) 0% 60 120,000 Common Stock
James E. Doyle Director Sale of securities on an exchange or to another person at price $ 42.02 per share. 13 Aug 2025 1,485 59,962 (0%) 0% 42.0 62,400 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2025 5,350 30,752 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2025 5,350 16,051 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.83 per share. 05 Aug 2025 2,515 28,237 (0%) 0% 46.8 117,777 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2025 5,350 27,943 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2025 5,350 16,051 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.83 per share. 05 Aug 2025 2,717 25,226 (0%) 0% 46.8 127,237 Common Stock
Katherine S. Zanotti Director Sale of securities on an exchange or to another person at price $ 53.20 per share. 12 Jun 2025 3,207 72,759 (0%) 0% 53.2 170,612 Common Stock
Katherine S. Zanotti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 5,398 75,966 (0%) 0% 0 Common Stock
Leslie L. Trigg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 7,670 17,169 (0%) 0% 0 Common Stock
Kimberly J. Popovits Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 9,994 16,381 (0%) 0% 0 Common Stock
Paul J. Clancy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 5,398 26,038 (0%) 0% 0 Common Stock
Daniel Joseph Levangie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 5,398 34,312 (0%) 0% 0 Common Stock
James E. Doyle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 5,398 61,447 (0%) 0% 0 Common Stock
D. Scott Coward Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 5,398 57,562 (0%) 0% 0 Common Stock
Shacey Petrovic Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 5,398 21,804 (0%) 0% 0 Common Stock
Michael J. Barber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 7,197 13,136 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 38.26 per share. 06 May 2025 363 15,585 (0%) 0% 38.3 13,888 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 May 2025 7,334 7,334 - - Restricted Stock Units
Leslie L. Trigg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2025 8,527 9,499 (0%) 0% 0 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 12,904 38,715 - - Restricted Stock Units
Aaron Bloomer EVP, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 12,904 19,340 (0%) 0% 0 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 11,566 0 - - Restricted Stock Units
Aaron Bloomer EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.25 per share. 15 Apr 2025 5,120 6,436 (0%) 0% 44.3 226,560 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 11,556 11,556 (0%) 0% 0 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.25 per share. 15 Apr 2025 5,717 13,623 (0%) 0% 44.2 252,977 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.38 per share. 07 Mar 2025 66,723 1,203,269 (0%) 0% 22.4 1,493,261 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Mar 2025 66,723 0 - - Stock Options (Right to Buy)
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.06 per share. 07 Mar 2025 48,929 1,154,340 (0%) 0% 47.1 2,302,599 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 4,725 25,001 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 4,948 14,845 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 4,725 9,450 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 2,326 25,402 (0%) 0% 47.8 111,229 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 4,948 27,728 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 2,221 22,780 (0%) 0% 47.8 106,208 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 18,143 1,133,326 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 22,167 66,504 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 18,143 36,286 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 10,419 1,136,546 (0%) 0% 47.8 498,237 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 22,167 1,146,965 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 8,528 1,124,798 (0%) 0% 47.8 407,809 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 3,958 84,399 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 1,777 80,441 (0%) 0% 47.8 84,976 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 3,780 82,218 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 3,958 11,876 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 3,780 7,560 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Gift of securities by or to the insider at price $ 0.00 per share. 28 Feb 2025 1,055 81,483 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 1,861 82,538 (0%) 0% 47.8 88,993 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 2,400 20,158 (0%) 0% 47.8 114,768 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 4,725 9,450 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 4,725 22,558 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 2,513 22,593 (0%) 0% 47.8 120,172 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 4,948 14,845 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 4,948 25,106 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 1,890 14,853 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 2,375 7,125 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 1,890 3,780 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 1,117 15,222 (0%) 0% 47.8 53,415 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Feb 2025 2,375 16,339 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. 28 Feb 2025 889 13,964 (0%) 0% 47.8 42,512 Common Stock
Jacob Orville EVP, GM, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 28,779 28,779 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 3,954 3,955 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 3,954 22,136 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. 24 Feb 2025 1,859 20,277 (0%) 0% 51.3 95,330 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 13,180 13,181 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 111,146 111,146 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 13,180 1,121,378 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. 24 Feb 2025 6,195 1,115,183 (0%) 0% 51.3 317,680 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 3,954 80,297 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. 24 Feb 2025 1,859 78,438 (0%) 0% 51.3 95,330 Common Stock
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 23,817 23,817 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 3,954 3,955 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 3,954 3,955 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 28,779 28,779 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. 24 Feb 2025 2,008 17,833 (0%) 0% 51.3 102,970 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 3,954 19,841 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 1,647 1,648 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 13,893 13,893 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. 24 Feb 2025 775 12,963 (0%) 0% 51.3 39,742 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Feb 2025 1,647 13,738 (0%) 0% 0 Common Stock
Aaron Bloomer EVP, Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2025 28,779 28,779 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 2,248 0 - - Restricted Stock Units
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.48 per share. 19 Feb 2025 2,225 18,182 (0%) 0% 50.5 112,318 Common Stock
Jacob Orville EVP, GM, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 4,805 20,407 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 2,248 16,688 (0%) 0% 0 Common Stock
Jacob Orville EVP, GM, Screening Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.63 per share. 19 Feb 2025 1,086 15,602 (0%) 0% 49.6 53,898 Common Stock
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 48,044 1,129,338 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 10,374 0 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 10,374 1,084,565 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.63 per share. 19 Feb 2025 3,271 1,081,294 (0%) 0% 49.6 162,340 Common Stock
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.48 per share. 19 Feb 2025 21,140 1,108,198 (0%) 0% 50.5 1,067,147 Common Stock
D. Scott Coward Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 2,248 0 - - Restricted Stock Units
D. Scott Coward Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 2,248 52,831 (0%) 0% 0 Common Stock
D. Scott Coward Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.63 per share. 19 Feb 2025 667 52,164 (0%) 0% 49.6 33,103 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 2,248 0 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 2,248 74,859 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.63 per share. 19 Feb 2025 1,107 73,752 (0%) 0% 49.6 54,940 Common Stock
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 4,805 78,557 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.48 per share. 19 Feb 2025 2,214 76,343 (0%) 0% 50.5 111,763 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 1,729 14,487 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 1,729 0 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.48 per share. 19 Feb 2025 2,437 15,887 (0%) 0% 50.5 123,020 Common Stock
Brian Baranick EVP, GM, Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 4,805 18,324 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.63 per share. 19 Feb 2025 968 13,519 (0%) 0% 49.6 48,042 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.63 per share. 19 Feb 2025 433 10,298 (0%) 0% 49.6 21,490 Common Stock
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 865 0 - - Restricted Stock Units
James Herriott SVP, General Counsel & Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Feb 2025 865 10,731 (0%) 0% 0 Common Stock
James Herriott SVP, General Counsel & Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.48 per share. 19 Feb 2025 1,531 12,091 (0%) 0% 50.5 77,285 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2025 3,324 13,622 (0%) 0% 0 Common Stock
Kimberly J. Popovits Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 6,387 6,387 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO 31 Dec 2024 74,599 779,944 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Purchase of securities on an exchange or from another person at price $ 51.35 per share. 13 Nov 2024 19,500 1,074,191 (0%) 0% 51.4 1,001,325 Common Stock
James Herriott SVP, General Counsel & Sec Sale of securities on an exchange or to another person at price $ 60.00 per share. 09 Oct 2024 1,500 14,085 (0%) 0% 60 90,000 Common Stock
Brian Baranick EVP, GM, Precision Oncology Sale of securities on an exchange or to another person at price $ 70.00 per share. 08 Oct 2024 929 12,758 (0%) 0% 70 65,030 Common Stock
Brian Baranick EVP, GM, Precision Oncology Sale of securities on an exchange or to another person at price $ 70.00 per share. 18 Sep 2024 929 13,687 (0%) 0% 70 65,030 Common Stock
Jacob Orville EVP, GM, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2024 21,401 21,401 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.77 per share. 05 Aug 2024 1,375 14,616 (0%) 0% 55.8 76,684 Common Stock
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2024 2,712 15,991 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM, Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2024 21,401 21,401 - - Restricted Stock Units
Brian Baranick EVP, GM, Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Aug 2024 2,712 0 - - Restricted Stock Units
Katherine S. Zanotti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,444 70,073 (0%) 0% 0 Common Stock
Paul J. Clancy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,444 20,145 (0%) 0% 0 Common Stock
Daniel Joseph Levangie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,444 28,419 (0%) 0% 0 Common Stock
James E. Doyle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,444 55,554 (0%) 0% 0 Common Stock
Scott D. Coward Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,444 50,088 (0%) 0% 0 Common Stock
Shacey Petrovic Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,444 15,911 (0%) 0% 0 Common Stock
Kathleen Sebelius Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 6,889 31,888 (0%) 0% 0 Common Stock
Michael J. Barber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 7,422 7,422 - - Deferred Stock Units
Michael J. Barber Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,444 5,444 (0%) 0% 0 Common Stock
Shacey Petrovic Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,939 16,406 (0%) 0% 0 Common Stock
Kathleen Sebelius Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 7,672 32,671 (0%) 0% 0 Common Stock
Paul Clancy J. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,939 20,640 (0%) 0% 0 Common Stock
Levangie Daniel Joseph Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,939 28,914 (0%) 0% 0 Common Stock
Coward Scott D. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,939 50,583 (0%) 0% 0 Common Stock
Doyle James E. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,939 56,049 (0%) 0% 0 Common Stock
Zanotti Katherine S. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,939 70,568 (0%) 0% 0 Common Stock
Barber J. Michael Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 5,939 5,939 (0%) 0% 0 Common Stock
Jacob Orville General Manager, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2024 218 14,542 (0%) 0% 0 Common Stock
Jacob Orville General Manager, Screening Sale of securities on an exchange or to another person at price $ 60.15 per share. 30 Apr 2024 102 14,440 (0%) 0% 60.1 6,135 Common Stock
Kevin T. Conroy Director, President and CEO Sale of securities on an exchange or to another person at price $ 60.15 per share. 30 Apr 2024 1,155 1,156,191 (0%) 0% 60.1 69,473 Common Stock
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 30.02 per share. 30 Apr 2024 708 1,157,346 (0%) 0% 30.0 21,254 Common Stock
Kevin T. Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2024 2,489 1,156,638 (0%) 0% 0 Common Stock
Everett V. Cunningham Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 30.02 per share. 30 Apr 2024 708 47,178 (0%) 0% 30.0 21,254 Common Stock
Everett V. Cunningham Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2024 291 46,470 (0%) 0% 0 Common Stock
Everett V. Cunningham Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 60.15 per share. 30 Apr 2024 136 47,042 (0%) 0% 60.1 8,180 Common Stock
D. Scott Coward Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2024 218 44,711 (0%) 0% 0 Common Stock
D. Scott Coward Director Sale of securities on an exchange or to another person at price $ 60.15 per share. 30 Apr 2024 67 44,644 (0%) 0% 60.1 4,030 Common Stock
Jeffrey T. Elliott Chief Financial Officer Grant, award, or other acquisition of securities at price $ 30.02 per share. 30 Apr 2024 707 11,931 (0%) 0% 30.0 21,224 Common Stock
Jeffrey T. Elliott Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2024 291 11,224 (0%) 0% 0 Common Stock
Jeffrey T. Elliott Chief Financial Officer Sale of securities on an exchange or to another person at price $ 60.15 per share. 30 Apr 2024 136 11,795 (0%) 0% 60.1 8,180 Common Stock
Sarah Condella EVP, Human Resources Sale of securities on an exchange or to another person at price $ 60.15 per share. 30 Apr 2024 102 72,611 (0%) 0% 60.1 6,135 Common Stock
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2024 218 72,005 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 30.02 per share. 30 Apr 2024 708 72,713 (0%) 0% 30.0 21,254 Common Stock
Brian Baranick EVP, GM., Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2024 218 13,389 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM., Precision Oncology Sale of securities on an exchange or to another person at price $ 60.15 per share. 30 Apr 2024 110 13,279 (0%) 0% 60.2 6,617 Common Stock
James Herriott SVP, General Counsel & Sec Sale of securities on an exchange or to another person at price $ 60.17 per share. 30 Apr 2024 30 9,866 (0%) 0% 60.2 1,805 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 30.02 per share. 30 Apr 2024 708 9,896 (0%) 0% 30.0 21,254 Common Stock
James Herriott SVP, General Counsel & Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2024 63 9,188 (0%) 0% 0 Common Stock
Brian Baranick EVP, GM., Precision Oncology Sale of securities on an exchange or to another person at price $ 79.43 per share. 02 Apr 2024 924 13,171 (0%) 0% 79.4 73,393 Common Stock
Sarah Condella EVP, Human Resources Sale of securities on an exchange or to another person at price $ 70.00 per share. 01 Apr 2024 2,000 71,787 (0%) 0% 70 140,000 Common Stock
Sarah Condella EVP, Human Resources Sale of securities on an exchange or to another person at price $ 70.00 per share. 28 Mar 2024 2,000 73,787 (0%) 0% 70 140,000 Common Stock
Daniel Joseph Levangie Director Sale of securities on an exchange or to another person at price $ 57.50 per share. 01 Mar 2024 5,000 22,975 (0%) 0% 57.5 287,500 Common Stock
James E. Doyle Director Sale of securities on an exchange or to another person at price $ 57.50 per share. 01 Mar 2024 2,000 50,110 (0%) 0% 57.5 115,000 Common Stock
Jacob Orville General Manager, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 4,724 16,478 (0%) 0% 0 Common Stock
Jacob Orville General Manager, Screening Sale of securities on an exchange or to another person at price $ 59.32 per share. 29 Feb 2024 2,154 14,324 (0%) 0% 59.3 127,775 Common Stock
Jacob Orville General Manager, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 4,724 14,175 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 18,143 1,307,767 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 18,143 54,429 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Sale of securities on an exchange or to another person at price $ 59.32 per share. 29 Feb 2024 8,271 1,299,496 (0%) 0% 59.3 490,636 Common Stock
Everett V. Cunningham Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 59.32 per share. 29 Feb 2024 2,412 46,179 (0%) 0% 59.3 143,080 Common Stock
Everett V. Cunningham Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 5,291 48,591 (0%) 0% 0 Common Stock
Everett V. Cunningham Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 5,291 15,876 - - Restricted Stock Units
Jeffrey T. Elliott Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 5,291 15,876 - - Restricted Stock Units
Jeffrey T. Elliott Chief Financial Officer Sale of securities on an exchange or to another person at price $ 59.32 per share. 29 Feb 2024 2,412 10,933 (0%) 0% 59.3 143,080 Common Stock
Jeffrey T. Elliott Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 5,291 13,345 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Sale of securities on an exchange or to another person at price $ 59.32 per share. 29 Feb 2024 1,724 75,787 (0%) 0% 59.3 102,268 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 3,779 11,340 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 3,779 77,511 (0%) 0% 0 Common Stock
Brian Baranick Gen. Mgr., Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 4,724 14,175 - - Restricted Stock Units
Brian Baranick Gen. Mgr., Precision Oncology Sale of securities on an exchange or to another person at price $ 59.32 per share. 29 Feb 2024 2,323 14,095 (0%) 0% 59.3 137,800 Common Stock
Brian Baranick Gen. Mgr., Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 4,724 16,418 (0%) 0% 0 Common Stock
James Herriott General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 1,890 9,987 (0%) 0% 0 Common Stock
James Herriott General Counsel Sale of securities on an exchange or to another person at price $ 59.32 per share. 29 Feb 2024 862 9,125 (0%) 0% 59.3 51,134 Common Stock
James Herriott General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Feb 2024 1,890 5,670 - - Restricted Stock Units
James Herriott General Counsel Sale of securities on an exchange or to another person at price $ 56.89 per share. 26 Feb 2024 784 8,097 (0%) 0% 56.9 44,602 Common Stock
V. Everett Cunningham Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 56.89 per share. 26 Feb 2024 3,648 43,300 (0%) 0% 56.9 207,535 Common Stock
Baranick Brian Gen. Mgr., Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2024 19,793 19,793 - - Restricted Stock Units
Condella Sarah EVP, Human Resources Sale of securities on an exchange or to another person at price $ 56.89 per share. 26 Feb 2024 1,880 73,732 (0%) 0% 56.9 106,953 Common Stock
Conroy Kevin T. Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2024 88,671 88,671 - - Restricted Stock Units
Baranick Brian Gen. Mgr., Precision Oncology Sale of securities on an exchange or to another person at price $ 56.89 per share. 26 Feb 2024 2,027 11,694 (0%) 0% 56.9 115,316 Common Stock
Elliott Jeffrey T. Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 5,701 11,401 - - Restricted Stock Units
Baranick Brian Gen. Mgr., Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 3,954 13,721 (0%) 0% 0 Common Stock
T. Jeffrey Elliott Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2024 4,750 4,750 - - Restricted Stock Units
Everett Cunningham V. Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 7,678 46,948 (0%) 0% 0 Common Stock
Orville Jacob General Manager, Screening Sale of securities on an exchange or to another person at price $ 56.89 per share. 26 Feb 2024 1,879 11,754 (0%) 0% 56.9 106,896 Common Stock
Conroy T. Kevin Director, President and CEO Sale of securities on an exchange or to another person at price $ 56.89 per share. 26 Feb 2024 6,263 1,289,624 (0%) 0% 56.9 356,302 Common Stock
James Herriott General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2024 9,500 9,500 - - Restricted Stock Units
T. Conroy Kevin Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 13,181 26,361 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 3,954 75,612 (0%) 0% 0 Common Stock
Everett Cunningham V. Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 7,678 15,356 - - Restricted Stock Units
Conroy T. Kevin Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 13,181 1,295,887 (0%) 0% 0 Common Stock
Baranick Brian Gen. Mgr., Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 3,954 7,909 - - Restricted Stock Units
Jacob Orville General Manager, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 3,954 13,633 (0%) 0% 0 Common Stock
T. Jeffrey Elliott Chief Financial Officer Sale of securities on an exchange or to another person at price $ 56.89 per share. 26 Feb 2024 2,710 8,054 (0%) 0% 56.9 154,172 Common Stock
Orville Jacob General Manager, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2024 19,793 19,793 - - Restricted Stock Units
Condella Sarah EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2024 15,834 15,834 - - Restricted Stock Units
James Herriott General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 1,648 3,295 - - Restricted Stock Units
Cunningham V. Everett Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2024 31,668 31,668 - - Restricted Stock Units
Jacob Orville General Manager, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 3,954 7,909 - - Restricted Stock Units
Herriott James General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 1,648 8,881 (0%) 0% 0 Common Stock
T. Elliott Jeffrey Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 5,701 10,764 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Feb 2024 3,954 7,909 - - Restricted Stock Units
T. Kevin Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.96 per share. 23 Feb 2024 102,837 1,344,266 (0%) 0% 14.0 1,435,605 Common Stock
T. Kevin Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2024 102,837 0 - - Stock Option (right to buy)
Kevin T. Conroy Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.53 per share. 23 Feb 2024 61,560 1,282,706 (0%) 0% 57.5 3,541,547 Common Stock
Condella Sarah EVP, Human Resources Sale of securities on an exchange or to another person at price $ 59.72 per share. 23 Feb 2024 1,021 71,658 (0%) 0% 59.7 60,974 Common Stock
T. Conroy Kevin Director, President and CEO Sale of securities on an exchange or to another person at price $ 59.78 per share. 21 Feb 2024 11,565 1,241,429 (0%) 0% 59.8 691,356 Common Stock
Baranick Brian Gen. Mgr., Precision Oncology Sale of securities on an exchange or to another person at price $ 59.78 per share. 21 Feb 2024 1,093 9,767 (0%) 0% 59.8 65,340 Common Stock
Jeffrey T. Elliott Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2024 2,711 6,414 (0%) 0% 0 Common Stock
Orville Jacob General Manager, Screening Sale of securities on an exchange or to another person at price $ 59.78 per share. 21 Feb 2024 1,013 9,679 (0%) 0% 59.8 60,557 Common Stock
Everett V. Cunningham Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2024 2,711 40,620 (0%) 0% 0 Common Stock
Herriott James General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2024 581 7,524 (0%) 0% 0 Common Stock
T. Kevin Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2024 23,238 1,252,994 (0%) 0% 0 Common Stock
T. Jeffrey Elliott Chief Financial Officer Sale of securities on an exchange or to another person at price $ 59.78 per share. 21 Feb 2024 1,351 5,063 (0%) 0% 59.8 80,763 Common Stock
Coward D. Scott Director Sale of securities on an exchange or to another person at price $ 59.78 per share. 21 Feb 2024 663 44,493 (0%) 0% 59.8 39,634 Common Stock
Baranick Brian Gen. Mgr., Precision Oncology Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2024 2,034 10,860 (0%) 0% 0 Common Stock
Jacob Orville General Manager, Screening Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2024 2,034 10,692 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2024 2,034 73,692 (0%) 0% 0 Common Stock
Condella Sarah EVP, Human Resources Sale of securities on an exchange or to another person at price $ 59.78 per share. 21 Feb 2024 1,013 72,679 (0%) 0% 59.8 60,557 Common Stock
D. Coward Scott Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2024 2,034 45,156 (0%) 0% 0 Common Stock
V. Everett Cunningham Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 59.78 per share. 21 Feb 2024 1,350 39,270 (0%) 0% 59.8 80,703 Common Stock
Herriott James General Counsel Sale of securities on an exchange or to another person at price $ 59.78 per share. 21 Feb 2024 291 7,233 (0%) 0% 59.8 17,396 Common Stock
T. Jeffrey Elliott Chief Financial Officer Sale of securities on an exchange or to another person at price $ 61.50 per share. 20 Feb 2024 1,493 3,703 (0%) 0% 61.5 91,820 Common Stock
Jacob Orville General Manager, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 2,248 9,736 (0%) 0% 0 Common Stock
Herriott James General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 864 0 - - Restricted Stock Units
Jacob Orville General Manager, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 2,248 0 - - Restricted Stock Units
T. Elliott Jeffrey Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 3,112 0 - - Restricted Stock Units
Condella Sarah EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 2,248 0 - - Restricted Stock Units
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 2,248 72,737 (0%) 0% 0 Common Stock
Kevin Conroy T. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 10,374 1,234,731 (0%) 0% 0 Common Stock
Brian Baranick Gen. Mgr., Precision Oncology Sale of securities on an exchange or to another person at price $ 61.50 per share. 20 Feb 2024 895 8,826 (0%) 0% 61.5 55,043 Common Stock
Baranick Brian Gen. Mgr., Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 1,729 9,721 (0%) 0% 0 Common Stock
Condella Sarah EVP, Human Resources Sale of securities on an exchange or to another person at price $ 61.50 per share. 20 Feb 2024 1,079 71,658 (0%) 0% 61.5 66,359 Common Stock
Coward Scott D. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 2,248 43,828 (0%) 0% 0 Common Stock
James Herriott General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 864 7,358 (0%) 0% 0 Common Stock
Orville Jacob General Manager, Screening Sale of securities on an exchange or to another person at price $ 61.50 per share. 20 Feb 2024 1,078 8,658 (0%) 0% 61.5 66,297 Common Stock
Baranick Brian Gen. Mgr., Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 1,729 0 - - Restricted Stock Units
Herriott James General Counsel Sale of securities on an exchange or to another person at price $ 61.50 per share. 20 Feb 2024 415 6,943 (0%) 0% 61.5 25,523 Common Stock
Scott D. Coward Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 2,248 0 - - Restricted Stock Units
Conroy Kevin T. Director, President and CEO Sale of securities on an exchange or to another person at price $ 61.50 per share. 20 Feb 2024 4,975 1,229,756 (0%) 0% 61.5 305,963 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 10,374 0 - - Restricted Stock Units
T. Jeffrey Elliott Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Feb 2024 3,112 5,196 (0%) 0% 0 Common Stock
Coward Scott D. Director Sale of securities on an exchange or to another person at price $ 61.50 per share. 20 Feb 2024 706 43,122 (0%) 0% 61.5 43,419 Common Stock
T. Kevin Conroy Director, President and CEO Grant, award, or other acquisition of securities at price $ 30.02 per share. 14 Feb 2024 709 1,208,015 (0%) 0% 30.0 21,284 Common Stock
Jacob Orville General Manager, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 2,031 8,454 (0%) 0% 0 Common Stock
D. Scott Coward Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 3,972 0 - - Restricted Stock Units
Kevin Conroy T. Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 31,133 1,239,148 (0%) 0% 0 Common Stock
James Herriott General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 883 0 - - Restricted Stock Units
Coward D. Scott Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 3,972 42,956 (0%) 0% 0 Common Stock
Coward Scott D. Director Sale of securities on an exchange or to another person at price $ 61.43 per share. 14 Feb 2024 1,376 41,580 (0%) 0% 61.4 84,528 Common Stock
T. Kevin Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 31,133 0 - - Restricted Stock Units
T. Jeffrey Elliott Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 3,972 3,972 (0%) 0% 0 Common Stock
Elliott T. Jeffrey Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 3,972 0 - - Restricted Stock Units
Condella Sarah EVP, Human Resources Sale of securities on an exchange or to another person at price $ 61.43 per share. 14 Feb 2024 965 70,489 (0%) 0% 61.4 59,280 Common Stock
Orville Jacob General Manager, Screening Sale of securities on an exchange or to another person at price $ 61.43 per share. 14 Feb 2024 966 7,488 (0%) 0% 61.4 59,341 Common Stock
James Herriott General Counsel Grant, award, or other acquisition of securities at price $ 30.01 per share. 14 Feb 2024 68 6,032 (0%) 0% 30.0 2,041 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 2,031 71,454 (0%) 0% 0 Common Stock
James Herriott General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 883 6,915 (0%) 0% 0 Common Stock
Sarah Condella EVP, Human Resources Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 2,031 0 - - Restricted Stock Units
Jacob Orville General Manager, Screening Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2024 2,031 0 - - Restricted Stock Units
James Herriott General Counsel Sale of securities on an exchange or to another person at price $ 61.43 per share. 14 Feb 2024 421 6,494 (0%) 0% 61.4 25,862 Common Stock
Conroy T. Kevin Director, President and CEO Sale of securities on an exchange or to another person at price $ 61.43 per share. 14 Feb 2024 14,791 1,224,357 (0%) 0% 61.4 908,611 Common Stock
Elliott T. Jeffrey Chief Financial Officer Sale of securities on an exchange or to another person at price $ 61.43 per share. 14 Feb 2024 1,888 2,084 (0%) 0% 61.4 115,980 Common Stock
Condella Sarah EVP, Human Resources Sale of securities on an exchange or to another person at price $ 73.50 per share. 02 Jan 2024 2,000 69,423 (0%) 0% 73.5 147,000 Common Stock
Baranick Brian Gen. Mgr., Precision Oncology Sale of securities on an exchange or to another person at price $ 73.50 per share. 02 Jan 2024 879 7,992 (0%) 0% 73.5 64,607 Common Stock
Condella Sarah EVP, Human Resources Sale of securities on an exchange or to another person at price $ 70.00 per share. 14 Dec 2023 2,000 71,423 (0%) 0% 70 140,000 Common Stock
Jeffrey T. Elliott Chief Financial Officer Sale of securities on an exchange or to another person at price $ 82.92 per share. 21 Aug 2023 30,210 0 (0%) 0% 82.9 2,505,013 Common Stock
Jeffrey T. Elliott Chief Financial Officer Grant, award, or other acquisition of securities at price $ 47.41 per share. 21 Aug 2023 260 29,501 (0%) 0% 47.4 12,327 Common Stock
Jeffrey T. Elliott Chief Financial Officer Grant, award, or other acquisition of securities at price $ 30.02 per share. 21 Aug 2023 709 30,210 (0%) 0% 30.0 21,284 Common Stock
Brian Baranick Gen. Mgr., Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Aug 2023 2,712 10,221 (0%) 0% 0 Common Stock
Brian Baranick Gen. Mgr., Precision Oncology Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Aug 2023 2,712 2,712 - - Restricted Stock Units
Brian Baranick Gen. Mgr., Precision Oncology Sale of securities on an exchange or to another person at price $ 85.04 per share. 04 Aug 2023 1,350 8,871 (0%) 0% 85.0 114,804 Common Stock
James E. Doyle Director Sale of securities on an exchange or to another person at price $ 97.42 per share. 27 Jul 2023 2,000 52,110 (0%) 0% 97.4 194,840 Common Stock
James Herriott General Counsel Sale of securities on an exchange or to another person at price $ 100.00 per share. 19 Jul 2023 1,300 5,964 (0%) 0% 100 130,000 Common Stock
Katherine S. Zanotti Director Sale of securities on an exchange or to another person at price $ 90.51 per share. 08 Jun 2023 3,027 64,629 (0%) 0% 90.5 273,974 Common Stock
Katherine S. Zanotti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 3,599 67,656 (0%) 0% 0 Common Stock
Paul J. Clancy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 3,599 14,701 (0%) 0% 0 Common Stock
Freda C. Lewis-Hall Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 3,599 19,688 (0%) 0% 0 Common Stock
Daniel Joseph Levangie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 4,678 27,975 (0%) 0% 0 Common Stock
James E. Doyle Director Sale of securities on an exchange or to another person at price $ 90.51 per share. 08 Jun 2023 1,402 54,110 (0%) 0% 90.5 126,895 Common Stock
James E. Doyle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 3,599 55,512 (0%) 0% 0 Common Stock
Scott D. Coward Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 6,209 38,984 (0%) 0% 0 Common Stock
Shacey Petrovic Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 3,599 17,562 (0%) 0% 0 Common Stock
Kathleen Sebelius Director 08 Jun 2023 3,599 24,999 (0%) 0% 0 Common Stock
Pierre Jacquet Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 4,580 23,576 (0%) 0% 0 Common Stock
James Herriott General Counsel Sale of securities on an exchange or to another person at price $ 90.00 per share. 08 Jun 2023 1,300 7,264 (0%) 0% 90 117,000 Common Stock
James E. Doyle Director Sale of securities on an exchange or to another person at price $ 80.62 per share. 26 May 2023 2,000 51,913 (0%) 0% 80.6 161,240 Common Stock
Sarah Condella EVP, Human Resources Sale of securities on an exchange or to another person at price $ 80.00 per share. 10 May 2023 6,087 80,314 (0%) 0% 80 486,960 Common Stock
James Herriott General Counsel Sale of securities on an exchange or to another person at price $ 79.85 per share. 10 May 2023 1,300 8,564 (0%) 0% 79.9 103,805 Common Stock
James Herriott General Counsel Grant, award, or other acquisition of securities at price $ 30.02 per share. 10 May 2023 640 9,864 (0%) 0% 30.0 19,213 Common Stock
Sarah Condella EVP, Human Resources Grant, award, or other acquisition of securities at price $ 30.02 per share. 01 May 2023 709 87,401 (0%) 0% 30.0 21,284 Common Stock
Sarah Condella EVP, Human Resources Sale of securities on an exchange or to another person at price $ 63.78 per share. 01 May 2023 1,000 86,401 (0%) 0% 63.8 63,780 Common Stock
Sarah Condella EVP, Human Resources Sale of securities on an exchange or to another person at price $ 67.19 per share. 03 Apr 2023 1,000 86,692 (0%) 0% 67.2 67,190 Common Stock
Everett V. Cunningham Chief Commercial Officer Sale of securities on an exchange or to another person at price $ 62.01 per share. 01 Mar 2023 3,628 22,703 (0%) 0% 62.0 224,972 Common Stock
Sarah Condella EVP, Human Resources Sale of securities on an exchange or to another person at price $ 62.00 per share. 01 Mar 2023 1,000 87,692 (0%) 0% 62 62,000 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 13,180 39,541 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 9,312 0 - - Restricted Stock Units
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 13,180 1,208,410 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 9,312 1,217,722 (0%) 0% 0 Common Stock
Kevin T. Conroy Director, President and CEO Sale of securities on an exchange or to another person at price $ 61.12 per share. 27 Feb 2023 10,416 1,207,306 (0%) 0% 61.1 636,626 Common Stock
Everett V. Cunningham Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 7,677 26,331 (0%) 0% 0 Common Stock
Everett V. Cunningham Chief Commercial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 7,677 23,034 - - Restricted Stock Units
Scott D. Coward Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 3,263 0 - - Restricted Stock Units
Scott D. Coward Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 5,931 33,665 (0%) 0% 0 Common Stock
Scott D. Coward Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 3,263 36,928 (0%) 0% 0 Common Stock
Scott D. Coward Director Sale of securities on an exchange or to another person at price $ 61.12 per share. 27 Feb 2023 4,153 32,775 (0%) 0% 61.1 253,831 Common Stock
Scott D. Coward Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 5,931 0 - - Restricted Stock Units
Jeffrey T. Elliott Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Feb 2023 3,437 0 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters